| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Retinal Degeneration | 12 | 2012 | 150 | 1.460 |
Why?
|
| Retina | 14 | 2012 | 433 | 1.140 |
Why?
|
| Docosahexaenoic Acids | 3 | 2010 | 91 | 0.780 |
Why?
|
| Eye Proteins | 6 | 2021 | 205 | 0.650 |
Why?
|
| Bacterial Toxins | 2 | 2012 | 267 | 0.590 |
Why?
|
| Light | 7 | 2012 | 118 | 0.520 |
Why?
|
| Adaptation, Ocular | 3 | 2004 | 7 | 0.460 |
Why?
|
| Protease Inhibitors | 2 | 2012 | 40 | 0.450 |
Why?
|
| Mutation | 3 | 2021 | 848 | 0.440 |
Why?
|
| Rhodopsin | 2 | 2010 | 40 | 0.420 |
Why?
|
| Antigens, Bacterial | 2 | 2012 | 161 | 0.410 |
Why?
|
| Photoreceptor Cells, Vertebrate | 4 | 2010 | 67 | 0.400 |
Why?
|
| Membrane Proteins | 3 | 2021 | 485 | 0.390 |
Why?
|
| Hydroxamic Acids | 1 | 2012 | 18 | 0.380 |
Why?
|
| Antitoxins | 1 | 2012 | 13 | 0.380 |
Why?
|
| Chelating Agents | 1 | 2012 | 22 | 0.380 |
Why?
|
| Electroretinography | 11 | 2012 | 178 | 0.370 |
Why?
|
| Radiation Injuries, Experimental | 3 | 2010 | 32 | 0.360 |
Why?
|
| Drug Design | 1 | 2011 | 63 | 0.350 |
Why?
|
| Animals | 28 | 2021 | 10399 | 0.320 |
Why?
|
| Rats, Sprague-Dawley | 12 | 2012 | 543 | 0.280 |
Why?
|
| Photoreceptor Cells | 2 | 2007 | 36 | 0.280 |
Why?
|
| Rats | 13 | 2021 | 1564 | 0.280 |
Why?
|
| P-Selectin | 3 | 1996 | 30 | 0.260 |
Why?
|
| Membrane Glycoproteins | 3 | 1996 | 145 | 0.260 |
Why?
|
| Anti-Bacterial Agents | 1 | 2011 | 523 | 0.260 |
Why?
|
| Estradiol | 5 | 2007 | 175 | 0.240 |
Why?
|
| Circadian Rhythm | 2 | 2004 | 76 | 0.220 |
Why?
|
| Apoptosis | 10 | 2010 | 771 | 0.220 |
Why?
|
| Fibroblast Growth Factor 2 | 3 | 2003 | 29 | 0.220 |
Why?
|
| Mice | 12 | 2012 | 4645 | 0.220 |
Why?
|
| Neuroprotective Agents | 5 | 2012 | 52 | 0.190 |
Why?
|
| Thioredoxins | 4 | 2010 | 26 | 0.190 |
Why?
|
| Lighting | 1 | 2001 | 9 | 0.190 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2021 | 22 | 0.180 |
Why?
|
| Radiation Injuries | 1 | 2001 | 52 | 0.180 |
Why?
|
| Neuronal Plasticity | 1 | 2021 | 50 | 0.180 |
Why?
|
| Spinocerebellar Ataxias | 1 | 2021 | 28 | 0.180 |
Why?
|
| Glycolipids | 1 | 2001 | 19 | 0.180 |
Why?
|
| Proteins | 5 | 2010 | 251 | 0.170 |
Why?
|
| Mice, Transgenic | 3 | 2010 | 509 | 0.160 |
Why?
|
| Retinal Ganglion Cells | 3 | 2009 | 26 | 0.160 |
Why?
|
| Cells, Cultured | 6 | 2012 | 985 | 0.160 |
Why?
|
| Hydroxylamine | 2 | 2010 | 9 | 0.150 |
Why?
|
| Cyclic N-Oxides | 2 | 2010 | 26 | 0.150 |
Why?
|
| Neuroglia | 1 | 1999 | 30 | 0.150 |
Why?
|
| Fatty Acids | 2 | 2010 | 204 | 0.150 |
Why?
|
| Thiocyanates | 2 | 2008 | 19 | 0.140 |
Why?
|
| Glaucoma | 2 | 2009 | 53 | 0.140 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2001 | 301 | 0.140 |
Why?
|
| Disease Models, Animal | 6 | 2010 | 1461 | 0.140 |
Why?
|
| Gene Expression | 3 | 2009 | 414 | 0.130 |
Why?
|
| Liver | 2 | 2010 | 434 | 0.130 |
Why?
|
| Kinetics | 3 | 2012 | 545 | 0.130 |
Why?
|
| Leukocytes | 2 | 1996 | 71 | 0.130 |
Why?
|
| E-Selectin | 1 | 1996 | 27 | 0.130 |
Why?
|
| Glycosyltransferases | 1 | 1996 | 31 | 0.120 |
Why?
|
| Oligosaccharides | 1 | 1996 | 33 | 0.120 |
Why?
|
| Blotting, Western | 7 | 2007 | 510 | 0.120 |
Why?
|
| Protein Processing, Post-Translational | 1 | 1996 | 102 | 0.120 |
Why?
|
| Immunohistochemistry | 4 | 2009 | 462 | 0.120 |
Why?
|
| Interleukin-18 | 4 | 2009 | 17 | 0.110 |
Why?
|
| Aldehydes | 2 | 2012 | 55 | 0.110 |
Why?
|
| Mice, Inbred C57BL | 5 | 2010 | 1570 | 0.110 |
Why?
|
| Hydrogen Peroxide | 4 | 2006 | 144 | 0.100 |
Why?
|
| Retinal Dehydrogenase | 1 | 2012 | 10 | 0.100 |
Why?
|
| Carnosine | 1 | 2012 | 8 | 0.100 |
Why?
|
| Hearing Loss, Sensorineural | 2 | 2010 | 24 | 0.100 |
Why?
|
| Erythropoietin | 1 | 2012 | 12 | 0.100 |
Why?
|
| Nerve Growth Factors | 2 | 2009 | 24 | 0.090 |
Why?
|
| Serpins | 2 | 2009 | 31 | 0.090 |
Why?
|
| Caspase 3 | 3 | 2008 | 57 | 0.090 |
Why?
|
| Retinal Rod Photoreceptor Cells | 1 | 2012 | 90 | 0.090 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2011 | 46 | 0.090 |
Why?
|
| Substrate Specificity | 1 | 2011 | 151 | 0.090 |
Why?
|
| Down-Regulation | 4 | 2009 | 198 | 0.090 |
Why?
|
| In Situ Nick-End Labeling | 3 | 2007 | 42 | 0.080 |
Why?
|
| Radiation-Protective Agents | 1 | 2010 | 24 | 0.080 |
Why?
|
| Piperidines | 1 | 2010 | 48 | 0.080 |
Why?
|
| Peptides | 1 | 2012 | 289 | 0.080 |
Why?
|
| Fatty Acid Desaturases | 1 | 2009 | 15 | 0.080 |
Why?
|
| Retinal Pigment Epithelium | 1 | 2010 | 97 | 0.080 |
Why?
|
| Pigment Epithelium of Eye | 2 | 2006 | 15 | 0.080 |
Why?
|
| Oxidants | 2 | 2006 | 31 | 0.080 |
Why?
|
| Macrophages | 1 | 2012 | 296 | 0.080 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2009 | 55 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2007 | 326 | 0.080 |
Why?
|
| Thioredoxin Reductase 1 | 1 | 2008 | 13 | 0.080 |
Why?
|
| Cochlea | 1 | 2008 | 20 | 0.080 |
Why?
|
| Molecular Sequence Data | 4 | 2004 | 1050 | 0.070 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2009 | 126 | 0.070 |
Why?
|
| CHO Cells | 3 | 1996 | 97 | 0.070 |
Why?
|
| Cricetinae | 3 | 1996 | 130 | 0.070 |
Why?
|
| Caspases | 2 | 2005 | 42 | 0.070 |
Why?
|
| Retinal Neovascularization | 1 | 2007 | 20 | 0.070 |
Why?
|
| Receptors, LDL | 1 | 2007 | 28 | 0.070 |
Why?
|
| RNA, Messenger | 4 | 2007 | 656 | 0.070 |
Why?
|
| Rod Opsins | 2 | 2004 | 14 | 0.070 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2012 | 129 | 0.070 |
Why?
|
| Up-Regulation | 2 | 2007 | 245 | 0.070 |
Why?
|
| Gene Products, gag | 1 | 2006 | 1 | 0.070 |
Why?
|
| Succinates | 1 | 2006 | 8 | 0.070 |
Why?
|
| Triterpenes | 1 | 2006 | 9 | 0.060 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2004 | 165 | 0.060 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2004 | 136 | 0.060 |
Why?
|
| Oxidative Stress | 2 | 2012 | 663 | 0.060 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2004 | 140 | 0.060 |
Why?
|
| HIV-1 | 1 | 2006 | 58 | 0.060 |
Why?
|
| Cell Count | 3 | 2010 | 86 | 0.060 |
Why?
|
| Glaucoma, Open-Angle | 1 | 2005 | 23 | 0.060 |
Why?
|
| ADP-Ribosylation Factors | 1 | 2004 | 5 | 0.060 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2004 | 12 | 0.060 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2004 | 31 | 0.060 |
Why?
|
| Mitochondrial Proton-Translocating ATPases | 1 | 2004 | 8 | 0.060 |
Why?
|
| Male | 4 | 2021 | 13487 | 0.060 |
Why?
|
| Electron Transport Complex IV | 1 | 2004 | 40 | 0.060 |
Why?
|
| Phosphorylation | 4 | 2007 | 575 | 0.060 |
Why?
|
| Neurons | 2 | 2004 | 282 | 0.060 |
Why?
|
| Transfection | 3 | 2009 | 318 | 0.050 |
Why?
|
| Glycosylation | 2 | 2012 | 70 | 0.050 |
Why?
|
| Humans | 9 | 2010 | 28121 | 0.050 |
Why?
|
| Antioxidants | 1 | 2006 | 225 | 0.050 |
Why?
|
| Rod Cell Outer Segment | 1 | 2004 | 42 | 0.050 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2003 | 15 | 0.050 |
Why?
|
| Epithelial Cells | 1 | 2005 | 247 | 0.050 |
Why?
|
| Nitric Oxide Synthase | 1 | 2003 | 34 | 0.050 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2004 | 35 | 0.050 |
Why?
|
| Female | 5 | 2021 | 15156 | 0.050 |
Why?
|
| Enzyme Activation | 2 | 2007 | 267 | 0.050 |
Why?
|
| Animals, Newborn | 2 | 2007 | 180 | 0.050 |
Why?
|
| Mice, Inbred DBA | 3 | 2009 | 30 | 0.050 |
Why?
|
| Lipoproteins | 1 | 2004 | 99 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 1 | 2004 | 153 | 0.050 |
Why?
|
| Estrogens | 1 | 2003 | 56 | 0.050 |
Why?
|
| Glial Fibrillary Acidic Protein | 3 | 2009 | 21 | 0.050 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2010 | 162 | 0.050 |
Why?
|
| Insulin | 1 | 2004 | 315 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinases | 3 | 2007 | 87 | 0.050 |
Why?
|
| Amino Acid Sequence | 3 | 2004 | 689 | 0.050 |
Why?
|
| Rats, Transgenic | 1 | 2021 | 12 | 0.050 |
Why?
|
| Motor Disorders | 1 | 2021 | 9 | 0.050 |
Why?
|
| Rats, Long-Evans | 1 | 2021 | 34 | 0.050 |
Why?
|
| NF-kappa B | 3 | 2007 | 191 | 0.050 |
Why?
|
| Organ Culture Techniques | 1 | 2021 | 56 | 0.050 |
Why?
|
| Rana pipiens | 1 | 2001 | 7 | 0.050 |
Why?
|
| Diglycerides | 1 | 2001 | 10 | 0.050 |
Why?
|
| Glycerol | 1 | 2001 | 16 | 0.050 |
Why?
|
| Type C Phospholipases | 1 | 2001 | 31 | 0.050 |
Why?
|
| Darkness | 1 | 2001 | 17 | 0.050 |
Why?
|
| Cerebellum | 1 | 2021 | 42 | 0.050 |
Why?
|
| Phosphatidylethanolamines | 1 | 2001 | 26 | 0.050 |
Why?
|
| Phosphatidylcholines | 1 | 2001 | 45 | 0.040 |
Why?
|
| Molecular Weight | 1 | 2001 | 119 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2007 | 156 | 0.040 |
Why?
|
| Signal Transduction | 4 | 2010 | 1433 | 0.040 |
Why?
|
| Second Messenger Systems | 1 | 1999 | 13 | 0.040 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1999 | 31 | 0.040 |
Why?
|
| Injections, Intraperitoneal | 2 | 2010 | 34 | 0.040 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 1999 | 33 | 0.040 |
Why?
|
| Protein Kinase C | 1 | 1999 | 73 | 0.040 |
Why?
|
| Wounds and Injuries | 1 | 2001 | 185 | 0.040 |
Why?
|
| Cyclic AMP | 1 | 1999 | 86 | 0.040 |
Why?
|
| Gene Expression Regulation | 3 | 2007 | 633 | 0.040 |
Why?
|
| Sulfoxides | 2 | 2008 | 6 | 0.040 |
Why?
|
| Isothiocyanates | 2 | 2008 | 11 | 0.040 |
Why?
|
| Nerve Fibers | 2 | 2009 | 53 | 0.040 |
Why?
|
| Mice, Mutant Strains | 2 | 2008 | 58 | 0.040 |
Why?
|
| Vision, Ocular | 2 | 2010 | 27 | 0.040 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2008 | 44 | 0.040 |
Why?
|
| Base Sequence | 2 | 1996 | 584 | 0.040 |
Why?
|
| Recombinant Proteins | 2 | 1996 | 413 | 0.040 |
Why?
|
| Electrophoretic Mobility Shift Assay | 2 | 2007 | 50 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 2 | 1996 | 329 | 0.030 |
Why?
|
| NF-E2-Related Factor 2 | 2 | 2008 | 121 | 0.030 |
Why?
|
| Brain-Derived Neurotrophic Factor | 2 | 2010 | 22 | 0.030 |
Why?
|
| Fucosyltransferases | 1 | 1996 | 4 | 0.030 |
Why?
|
| Carbohydrate Sequence | 1 | 1996 | 14 | 0.030 |
Why?
|
| HL-60 Cells | 1 | 1996 | 22 | 0.030 |
Why?
|
| Microscopy, Electron | 1 | 1996 | 94 | 0.030 |
Why?
|
| Epitope Mapping | 1 | 1996 | 38 | 0.030 |
Why?
|
| N-Acetylglucosaminyltransferases | 1 | 1996 | 15 | 0.030 |
Why?
|
| Intraocular Pressure | 2 | 2007 | 62 | 0.030 |
Why?
|
| Testis | 1 | 1996 | 35 | 0.030 |
Why?
|
| DNA Primers | 1 | 1996 | 146 | 0.030 |
Why?
|
| Tamoxifen | 2 | 2007 | 33 | 0.030 |
Why?
|
| Ligands | 1 | 1996 | 176 | 0.030 |
Why?
|
| Cell Survival | 2 | 2010 | 407 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2006 | 192 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 1996 | 268 | 0.030 |
Why?
|
| Tetrazolium Salts | 2 | 2006 | 9 | 0.030 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 1995 | 13 | 0.030 |
Why?
|
| Epitopes | 1 | 1996 | 179 | 0.030 |
Why?
|
| Binding Sites | 1 | 1996 | 354 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1996 | 233 | 0.030 |
Why?
|
| Thiazoles | 2 | 2006 | 51 | 0.030 |
Why?
|
| Cell Adhesion | 1 | 1995 | 138 | 0.030 |
Why?
|
| Enzyme Inhibitors | 2 | 2007 | 249 | 0.030 |
Why?
|
| Neutrophils | 1 | 1995 | 181 | 0.030 |
Why?
|
| Blotting, Northern | 2 | 2004 | 46 | 0.030 |
Why?
|
| Gene Expression Profiling | 2 | 2005 | 451 | 0.020 |
Why?
|
| BALB 3T3 Cells | 1 | 2012 | 5 | 0.020 |
Why?
|
| Receptor, Insulin | 2 | 2004 | 94 | 0.020 |
Why?
|
| Hematinics | 1 | 2012 | 1 | 0.020 |
Why?
|
| Darbepoetin alfa | 1 | 2012 | 2 | 0.020 |
Why?
|
| Intravitreal Injections | 1 | 2012 | 34 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2012 | 69 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2012 | 190 | 0.020 |
Why?
|
| Glial Cell Line-Derived Neurotrophic Factor | 1 | 2010 | 3 | 0.020 |
Why?
|
| Aging | 2 | 2008 | 976 | 0.020 |
Why?
|
| Optic Nerve | 1 | 2009 | 28 | 0.020 |
Why?
|
| Nerve Degeneration | 1 | 2008 | 23 | 0.020 |
Why?
|
| Anticarcinogenic Agents | 1 | 2008 | 16 | 0.020 |
Why?
|
| Cell Death | 1 | 2009 | 118 | 0.020 |
Why?
|
| Visual Acuity | 1 | 2009 | 111 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2009 | 248 | 0.020 |
Why?
|
| Digoxigenin | 1 | 2007 | 1 | 0.020 |
Why?
|
| Drug Implants | 1 | 2007 | 14 | 0.020 |
Why?
|
| Spin Labels | 1 | 2007 | 19 | 0.020 |
Why?
|
| Oncogene Protein v-akt | 1 | 2007 | 8 | 0.020 |
Why?
|
| Estrogen Antagonists | 1 | 2007 | 16 | 0.020 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2007 | 58 | 0.020 |
Why?
|
| Thioredoxin-Disulfide Reductase | 1 | 2007 | 14 | 0.020 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2007 | 25 | 0.020 |
Why?
|
| Flavonoids | 1 | 2007 | 33 | 0.020 |
Why?
|
| Lipid Peroxidation | 1 | 2007 | 47 | 0.020 |
Why?
|
| Ovariectomy | 1 | 2007 | 53 | 0.020 |
Why?
|
| gag Gene Products, Human Immunodeficiency Virus | 1 | 2006 | 7 | 0.020 |
Why?
|
| Protein Precursors | 1 | 2006 | 11 | 0.020 |
Why?
|
| Capsid Proteins | 1 | 2006 | 12 | 0.020 |
Why?
|
| Hydrolysis | 1 | 2006 | 60 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2007 | 178 | 0.020 |
Why?
|
| Virus Replication | 1 | 2006 | 64 | 0.020 |
Why?
|
| Arrestin | 1 | 2005 | 11 | 0.020 |
Why?
|
| Transducin | 1 | 2005 | 13 | 0.020 |
Why?
|
| Cytochromes c | 1 | 2005 | 13 | 0.020 |
Why?
|
| Iris | 1 | 2005 | 8 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2005 | 112 | 0.020 |
Why?
|
| Ciliary Body | 1 | 2005 | 7 | 0.020 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2005 | 11 | 0.020 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 2005 | 19 | 0.020 |
Why?
|
| Receptors, Estrogen | 1 | 2005 | 43 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2005 | 124 | 0.020 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2005 | 40 | 0.020 |
Why?
|
| Protein Transport | 1 | 2005 | 157 | 0.010 |
Why?
|
| Lectins, C-Type | 1 | 2005 | 43 | 0.010 |
Why?
|
| trans-Golgi Network | 1 | 2004 | 2 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2006 | 288 | 0.010 |
Why?
|
| Endopeptidases | 1 | 2004 | 20 | 0.010 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2004 | 25 | 0.010 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2004 | 31 | 0.010 |
Why?
|
| Age Factors | 1 | 2007 | 733 | 0.010 |
Why?
|
| Vesicular Transport Proteins | 1 | 2004 | 34 | 0.010 |
Why?
|
| RNA, Transfer, Gly | 1 | 2004 | 1 | 0.010 |
Why?
|
| Expressed Sequence Tags | 1 | 2004 | 8 | 0.010 |
Why?
|
| Endosomes | 1 | 2004 | 45 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2005 | 140 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2004 | 34 | 0.010 |
Why?
|
| Electron Transport Complex I | 1 | 2004 | 13 | 0.010 |
Why?
|
| RNA, Ribosomal | 1 | 2004 | 51 | 0.010 |
Why?
|
| Amyloid beta-Peptides | 1 | 2004 | 49 | 0.010 |
Why?
|
| Models, Biological | 1 | 2007 | 465 | 0.010 |
Why?
|
| HeLa Cells | 1 | 2004 | 208 | 0.010 |
Why?
|
| Dietary Fats, Unsaturated | 1 | 2004 | 6 | 0.010 |
Why?
|
| Chromatography, Gas | 1 | 2004 | 18 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2007 | 845 | 0.010 |
Why?
|
| Hippocalcin | 1 | 2004 | 4 | 0.010 |
Why?
|
| Recoverin | 1 | 2004 | 4 | 0.010 |
Why?
|
| Animals, Genetically Modified | 1 | 2004 | 54 | 0.010 |
Why?
|
| Chromones | 1 | 2004 | 11 | 0.010 |
Why?
|
| DNA Fragmentation | 1 | 2004 | 17 | 0.010 |
Why?
|
| Glutathione Transferase | 1 | 2004 | 32 | 0.010 |
Why?
|
| src Homology Domains | 1 | 2004 | 31 | 0.010 |
Why?
|
| Fatty Acids, Omega-6 | 1 | 2004 | 19 | 0.010 |
Why?
|
| Morpholines | 1 | 2004 | 28 | 0.010 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2004 | 94 | 0.010 |
Why?
|
| Coloring Agents | 1 | 2004 | 35 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2004 | 198 | 0.010 |
Why?
|
| Calcium-Binding Proteins | 1 | 2004 | 61 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2005 | 283 | 0.010 |
Why?
|
| Progesterone | 1 | 2004 | 129 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2004 | 605 | 0.010 |
Why?
|
| Protein Binding | 1 | 2004 | 656 | 0.010 |
Why?
|
| Dietary Supplements | 1 | 2004 | 239 | 0.010 |
Why?
|
| Ciliary Neurotrophic Factor | 1 | 2001 | 2 | 0.010 |
Why?
|
| Fibroblast Growth Factor 1 | 1 | 2001 | 10 | 0.010 |
Why?
|
| Mitochondria | 1 | 2004 | 366 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2001 | 390 | 0.010 |
Why?
|
| Friction | 1 | 1995 | 5 | 0.010 |
Why?
|
| Microvilli | 1 | 1995 | 7 | 0.010 |
Why?
|
| Microscopy, Immunoelectron | 1 | 1995 | 10 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1995 | 206 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 1995 | 114 | 0.010 |
Why?
|